Diabetes is the most common disorder resulting in many long term complications such as retinopathy, neuropathy and nephropathy. These long term complications are prevented by maintaining the target glycemic level (HbA1c <7%) which is often not achieved by the diabetic patients despite the availability of many treatment modalities. Several studies depicted the positive influence of clinical pharmacist-led programs on achieving and maintaining glycemic control and other biomedical marker outcomes in diabetes patients. To assess the impact of clinical pharmacist-led program on achieving glycemic control in diabetic patients is the primary objective and the improvement in other outcomes like blood pressure, BMI and self-reported medication adherence are the secondary objectives. Clinical pharmacist-led pharmaceutical intervention program improved the glycemic control in diabetic patients whereas the traditional treatment control group did show any improvement. The secondary biomarkers blood pressure and medication adherence also has improved in the intervention group.